Empagliflozin as a novel therapy for cirrhotic refractory ascites: a randomized controlled study
Abstract Background Cirrhotic refractory ascites (RA) patients have few alternatives for treatment. Empagliflozin is now known to have natriuretic and neurohormonal modulatory effects. This research investigated the safety and efficacy of empagliflozin in the management of RA when added to the stand...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SpringerOpen
2024-10-01
|
| Collection: | Egyptian Liver Journal |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1186/s43066-024-00383-y |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|